Match tier Listed
Presence Current · Arkansas
Last published 2024
Sources OpenAlex · ORCID
Refreshed 2026-08-17

Gregory Pellar

Researcher

Also affiliated: United States Food and Drug Administration (2024)

Graduate Student Researcher

1 h-index 1 pubs 8 cited

  • Cotinine
  • Nicotine
  • Rats, Sprague-Dawley
  • Administration, Inhalation
  • Administration, Oral
  • Animals
  • Biological Availability
  • Half-Life
  • Infusions, Intravenous
  • Male
  • Tissue Distribution
  • Rats

Biography and Research Information

OverviewAI-generated summary

Gregory Pellar's research focuses on the pharmacokinetics of nicotine and its metabolites, specifically cotinine and <i>trans</i>-3′-hydroxycotinine. His work investigates how these substances are absorbed and eliminated in male Sprague-Dawley rats through different administration routes, including nose-only inhalation, oral gavage, and intravenous infusion. Pellar has published one study detailing these pharmacokinetic analyses, which contributes to understanding the biological availability and half-life of nicotine and its primary metabolites. His research is conducted at the National Center for Toxicological Research and involves collaboration with Matthew Bryant, Xiaobo He, Seonggi Min, and Florence McLellen.

Metrics

  • h-index: 1
  • Publications: 1
  • Citations: 8

Selected Publications

  • Pharmacokinetic analysis of nicotine and its metabolites (cotinine and <i>trans</i>-3′-hydroxycotinine) in male Sprague-Dawley rats following nose-only inhalation, oral gavage, and intravenous infusion of nicotine (2024)
    Toxicological Sciences 8 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

24 Collaborators 3 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics